Corixa Issues Clarification to Statement Made During Conference Call Regarding MDS Nordion Manufacturing Shut Down in December.Business Editors/Health/Medical Writers BIOWIRE2K SEATTLE--(BUSINESS WIRE)--Nov. 7, 2003 Corixa Corporation (Nasdaq:CRXA) today clarified a comment made during its third quarter earnings conference call regarding the BEXXAR manufacturing schedule in the fourth quarter of 2003. The company clarified that during the month of December December: see month. , MDS MDS, n See temporomandibular pain-dysfunction syndrome. MDS 1 Maternal deprivation syndrome, see there 2 Myelodysplastic syndrome, see there Nordion will shut down its BEXXAR operations for a few weeks to conduct annual routine preventative maintenance activities. According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. MDS Nordion, other MDS Nordion radiochemical operations will remain in full operation during this time. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion